부산대학교 도서관

Morschhauser, F; Dahiya, S; Palomba, ML; Garcia-Sancho, AM; Reguera-Ortega, JL; Kuruvilla, J; Jaeger, U; Cartron, G; Izutsu, K; Dreyling, M

NATURE MEDICINE. 30(8):2199-2207

Izutsu K; National Cancer Center Hospital, Tokyo, Japan.; Fukuhara N; Tohoku University Hospital, Sendai, Miyagi, Japan.; Yuda J; National Cancer Center Hospital East, Chiba, Japan.; Suehiro Y; National Hospital Organization Kyushu Cancer Center, Fukuoka City, Japan.; Kusumoto S; Aichi Cancer Center Hospital, Nagoya, Japan.; Casadebaig ML; Incyte International Biosciences Sàrl, Morges, Switzerland.; Suzukawa K; Incyte Biosciences Japan G.K, Tokyo, Japan.; Fukushima K; The University of Osaka Hospital, Suita, Japan.

Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE

M. Frascione; U. Vitolo; W. Jurczak; P.J. Lugtenburg; E. Gyan; J. C. Chavez; A. Sureda; J. Haaber Christensen; H. Tilly; R. Cordoba; D. J. Lewis; M. Hutchings; M. Roost Clausen; J-M. Sancho; T. Cochrane; S. Leppä; M.E. D. Chamuleau; C. Thieblemont; K. Izutsu; N. Fukuhara; P. F. Caimi; Y. H. Karimi; C. andreadis; J.M. Vose; E. Favaro; P. Patah; M. Geybels; I. Altintas; C. Morehouse; K.M. Linton

Haematologica, Vol 110, Iss s1 (2025)

Goto H; Hokkaido University Hospital, Kita-14, Nishi-5, Kita-ku, Sapporo-shi, Hokkaido, 060-8648, Japan. hidekigt0220@gmail.com.; Ito S; Yamagata University Hospital, Yamagata, Japan.; Kizaki M; Saitama Medical Center, Saitama Medical University, Saitama, Japan.; Yamaguchi M; Ishikawa Prefectural Central Hospital, Ishikawa, Japan.; Fukuhara N; Tohoku University Hospital, Miyagi, Japan.; Kato K; Kyushu University Hospital, Fukuoka, Japan.; Saito T; Aichi Cancer Center, Aichi, Japan.; Terui Y; Saitama Medical University Hospital, Saitama, Japan.; Soshin T; AbbVie, Tokyo, GK, Japan.; Satomi-Tsushita N; AbbVie, Tokyo, GK, Japan.; Honda H; AbbVie, Tokyo, GK, Japan.; Qian C; AbbVie, Inc, North Chicago, IL, USA.; Izutsu K; National Cancer Center Hospital, Tokyo, Japan.

Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Hamada T; Department of Dermatology, International University of Health and Welfare, Narita, Japan.; Sugaya M; Department of Dermatology, International University of Health and Welfare, Narita, Japan.; Sakaida T; Division of Dermatology, Konan Kosei Hospital, Konan, Japan.; Hirai Y; Department of Dermatology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Boki H; Department of Dermatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.; Shimauchi T; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Hisamoto T; Department of Dermatology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan.; Kiyohara E; Department of Dermatology, Course of Integrated Medicine Graduate School of Medicine, The University of Osaka, Suita, Japan.; Fujii K; Department of Dermatology, Kindai University Hospital, Osaka, Japan.; Sunagawa K; Department of Dermatology, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University, Okayama, Japan.; Ozaki S; Department of Dermatology, Nippon Medical School, Tokyo, Japan.; Ohnishi K; Department of Radiology, International University of Health and Welfare, Narita, Japan.; Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Shiratori S; Department of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan.; Amagai R; Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.; Yonekura K; Department of Dermatology, Imamura General Hospital, Kagoshima, Japan.; Iwata M; Department of Dermatology, Faculty of Medicine, Kagawa University, Miki-cho, Japan.; Miyagaki T; Department of Dermatology, St. Marianna University School of Medicine, Kawasaki, Japan.; Koga H; Kitatoda Alps Dermatology Clinic, Toda, Japan.; Uchi H; Department of Dermato-Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.; Nakamura Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE

Nanjo, K. Z.; Izutsu, J.; Orihara, Y.; Kamogawa, M.

Coombs CC; University of California Irvine, Irvine, CA, USA.; Woyach JA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Brown JR; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Ghia P; Universita Vita-Salute San Raffaele Milano, Milano, Italy.; IRCCS Ospedale San Raffaele, Milano, Italy.; Roeker LE; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Patel K; Swedish Cancer Institute, Seattle, WA, USA.; Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, UK.; Tam CS; Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Seymour JF; Royal Melbourne Hospital, Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC, Australia.; Shah NN; Medical College of Wisconsin, Milwaukee, WI, USA.; Flinn I; Sarah Cannon Research Institute/Tennessee Oncology/OneOncology, Nashville, TN, USA.; Cheah CY; Linear Clinical Research and Sir Charles Gairdner Hospital and University of Western Australia, Perth, WA, Australia.; Ma S; Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.; Rhodes JM; Rutgers Cancer Institute, New Brunswick, NJ, USA.; Izutsu K; National Cancer Center Hospital, Tokyo, Japan.; Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.; Wierda WG; MD Anderson Cancer Center, Houston, TX, USA.; Hess LM; Eli Lilly and Company, Indianapolis, IN, USA.; Bhandari NR; Eli Lilly and Company, Indianapolis, IN, USA.; Loubert A; Modus Outcomes, Lyon, France.; Abada PB; Eli Lilly and Company, Indianapolis, IN, USA.; Lamanna N; Herbert Irving Comprehensive Cancer Center, Columbia University, New Year, NY, USA.

Publisher: Informa Healthcare Country of Publication: England NLM ID: 0351014 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-4877 (Electronic) Linking ISSN: 03007995 NLM ISO Abbreviation: Curr Med Res Opin Subsets: MEDLINE

Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Akahane D; Department of Hematology, Tokyo Medical University, Tokyo, Japan.; Toubai T; Department of Internal Medicine III, Division of Hematology and Cell Therapy, Yamagata University Faculty of Medicine, Yamagata, Japan.; Saito T; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.; Mishima Y; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Fujisaki T; Department of Hematology, Japan Red Cross Society, Matsuyama Red Cross Hospital, Matsuyama, Japan.; Nishikori M; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Kumode T; Department of Hematology and Rheumatology, Kindai University, Osaka, Japan.; Suehiro Y; Department of Hematology and Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.; Ishitsuka K; Department of Hematology and Rheumatology, Kagoshima University, Kagoshima, Japan.; Conlon R; AbbVie, North Chicago, IL, USA.; Takahashi A; Genmab, Tokyo, Japan.; D'Angelo Månsson B; Genmab, Copenhagen, Denmark.; Favaro E; Genmab, Copenhagen, Denmark.; Fukuhara N; Department of Hematology, Tohoku University, Sendai, Japan.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Ochi T; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Makita S; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. smakita@ncc.go.jp.; Hiratsuka A; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Nishiyama R; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Ito K; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan.; Maeshima AM; Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.; Takeda W; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.; Iwaki N; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Fukuhara S; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Munakata W; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Izutsu K; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.

Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Izutsu K; Department of Hematology, National Cancer Center Hospital, Tsukiji 5-1-1, Chuo-ku, Tokyo, 104-0045, Japan. kizutsu@ncc.go.jp.; Akahane D; Department of Hematology, Tokyo Medical University, Tokyo, Japan.; Toubai T; Department of Internal Medicine III, Division of Hematology and Cell Therapy, Faculty of Medicine, Yamagata University, Yamagata, Japan.; Saito T; Department of Hematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.; Mishima Y; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Fujisaki T; Department of Hematology, Japan Red Cross Society, Matsuyama Red Cross Hospital, Matsuyama, Japan.; Nishikori M; Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Kumode T; Department of Hematology and Rheumatology, Kindai University, Osaka, Japan.; Suehiro Y; Department of Hematology and Cell Therapy, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.; Ishitsuka K; Department of Hematology and Rheumatology, Kagoshima University, Kagoshima, Japan.; Patah P; AbbVie, North Chicago, IL, USA.; Takahashi A; Genmab, Tokyo, Japan.; Månsson BD; Genmab, Copenhagen, Denmark.; Favaro E; Genmab, Copenhagen, Denmark.; Fukuhara N; Department of Hematology, Tohoku University, Sendai, Japan.

Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

Takizawa J; Faculty of Medicine, Niigata University, 754, Asahimachi-dori Ichiban Chou, Chuo-ku, Niigata, 951-8520, Japan. juntaki@med.niigata-u.ac.jp.; Yoshida I; National Hospital Organization Shikoku Cancer Center, Ehime, Japan.; Ogawa Y; Tokai University Hospital, Kanagawa, Japan.; Toubai T; Yamagata University Hospital, Yamagata, Japan.; Kusumoto S; Aichi Cancer Center Hospital, Aichi, Japan.; Watanabe M; Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.; Ogawa N; AbbVie GK, Tokyo, Japan.; Satomi N; AbbVie GK, Tokyo, Japan.; Nishimura Y; AbbVie GK, Tokyo, Japan.; Honda H; AbbVie GK, Tokyo, Japan.; Chyla B; AbbVie Inc., North Chicago, IL, USA.; Izutsu K; National Cancer Center Hospital, Tokyo, Japan.

Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

Izutsu K; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. kizutsu@ncc.go.jp.; Watanabe M; Hyogo Prefectural Amagasaki General Medical Center, Hyogo, Japan.; Toubai T; Yamagata University Hospital, Yamagata, Japan.; Tsukamoto T; University Hospital Kyoto Prefectural University of Medicine, Kyoto, Japan.; Maruyama D; Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Kumode T; Kindai University Hospital, Osaka, Japan.; Fukuhara N; Tohoku University Hospital, Miyagi, Japan.; Ogawa N; AbbVie GK, Tokyo, Japan.; Satomi N; AbbVie GK, Tokyo, Japan.; Nishimura Y; AbbVie GK, Tokyo, Japan.; Honda H; AbbVie GK, Tokyo, Japan.; Chyla B; AbbVie Inc., North Chicago, IL, USA.; Takizawa J; Niigata University Faculty of Medicine, Niigata, Japan.

Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

Harvard Journal of Asiatic Studies, 1980 Dec 01. 40(2), 399-464.

Kato K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan. kato.koji.429@m.kyushu-u.ac.jp.; Nakamura S; MSD.K.K., 1-13-12 Kudan-Kita, Chiyoda-Ku, Tokyo, 102-0073, Japan.; Wakana A; MSD.K.K., 1-13-12 Kudan-Kita, Chiyoda-Ku, Tokyo, 102-0073, Japan.; Koh Y; MSD.K.K., 1-13-12 Kudan-Kita, Chiyoda-Ku, Tokyo, 102-0073, Japan.; Izutsu K; National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.

Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Palomba ML; Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: palombam@mskcc.org.; Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Karmali R; Northwestern University Feinberg School of Medicine, Robert H Lurie Comprehensive Cancer Center, Chicago, IL, USA.; Skarbnik AP; Novant Health Cancer Institute, Charlotte, NC, USA.; Abramson JS; Lymphoma Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.; Ardeshna K; University College London Hospitals Biomedical Research Centre, London, UK.; Borchmann P; Universität zu Köln, Albertus-Magnus-Platz, Cologne, Germany.; Hill BT; Cleveland Clinic, Cleveland, OH, USA.; García-Sancho AM; Hospital Universitario de Salamanca, IBSAL, CIBERONC, Universidad de Salamanca, Salamanca, Spain.; Marcacci G; National Cancer Institute, Fondazione 'G Pascale', IRCCS, Naples, Italy.; Rapoport AP; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.; Cartron G; Montpellier University Hospital Center, UMR CNRS, Montpellier, France.; Fleury I; Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada.; Izutsu K; National Cancer Center Hospital, Chuo City, Tokyo, Japan.; Kamdar M; University of Colorado Cancer Center, Aurora, CO, USA.; Mielke S; Departments of Laboratory Medicine and Medicine at Huddinge, Center of Allogeneic Stem Cell Transplantation and Cellular Therapy, Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, H5 Laboratories Medicine, Stockholm, Sweden.; Barbui AM; Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.; Ortega JLR; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla, Universidad de Sevilla, Seville, Spain.; Nastoupil LJ; Southwest Oncology, CommonSpirit Mercy, Durango, CO, USA.; Ahmed S; MD Anderson Cancer Center, Houston, TX, USA.; Bar M; Bristol Myers Squibb, Boudry, Switzerland.; Diaz L; Bristol Myers Squibb, Boudry, Switzerland.; Furustrand U; Bristol Myers Squibb, Boudry, Switzerland.; Diab V; Bristol Myers Squibb, Princeton, NJ, USA.; Vedal M; Bristol Myers Squibb, Boudry, Switzerland.; Avilion A; Bristol Myers Squibb, Seattle, WA, USA.; Kumar J; Bristol Myers Squibb, Princeton, NJ, USA.; Nishii R; Bristol Myers Squibb, Princeton, NJ, USA.; Colicino S; Bristol Myers Squibb, Boudry, Switzerland.; Morschhauser F; Département d'Hématologie, Université de Lille, Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France.

Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: MEDLINE

Makita S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan. smakita@ncc.go.jp.; Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Mishima Y; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.; Kumode T; Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka, Japan.; Kuroda J; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan.; Kanemura N; Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan.; Fukuhara N; Department of Hematology, Tohoku University, Sendai, Japan.; Shimada K; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Mori C; Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.; Kawasaki A; Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.; Miyake T; Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.; Maruyama D; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE

Satake A; Kansai Medical University, Hirakata, Japan. satake.ats@kmu.ac.jp.; Nagate Y; NHO Osaka National Hospital, Osaka, Japan.; Miyawaki K; Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.; Fujiwara Y; Japanese Red Cross Society Himeji Hospital, Himeji, Japan.; Ota S; Sapporo Hokuyu Hospital, Sapporo, Japan.; Muta T; Hiroshima Red Cross Hospital, Hiroshima, Japan.; Rai S; Kindai University, Osaka, Japan.; Tsurumi H; Matsunami General Hospital, Kasamatsu, Japan.; Suzuki R; Shimane University Hospital, Izumo, Japan.; Miyake T; Shimane Prefectural Central Hospital, Izumo, Japan.; Goto H; Hokkaido University Hospital, Sapporo, Japan.; Fukuhara N; Tohoku University, Sendai, Japan.; Sakata-Yanagimoto M; University of Tsukuba, Tsukuba, Japan.; Izutsu K; National Cancer Center Hospital, Tokyo, Japan.; Nishikori M; Kyoto University Hospital, Kyoto, Japan.; Shibayama H; NHO Osaka National Hospital, Osaka, Japan.; Kumode T; Kindai University, Osaka, Japan.; Ennishi D; Okayama University Hospital, Okayama, Japan.; Shimose T; Clinical Research Support Center Kyushu, Fukuoka, Japan.; Inubashiri N; Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.; Matsumura I; Kindai University, Osaka, Japan.; Akashi K; Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.; Kato K; Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

Nakai R; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Maruyama D; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. dmaruyam@ncc.go.jp.; Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. dmaruyam@ncc.go.jp.; Miyagi-Maeshima A; Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.; Makita S; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Fukuhara S; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Munakata W; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Suzuki T; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Igaki H; Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan.; Suzuki S; Department of Ophthalmic Oncology, National Cancer Center Hospital, Tokyo, Japan.; Tobinai K; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Izutsu K; Department of Hematology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. kizutsu@ncc.go.jp.

Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE

Yokoyama H; Department of Hematology and Cell Therapy, Yamagata University Hospital, Yamagata, Japan.; Fukuhara N; Department of Hematology, Tohoku University Hospital, Sendai, Japan.; Ando K; Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.; Iida H; Department of Hematology, NHO Nagoya Medical Center, Nagoya, Japan.; Yamauchi T; Department of Hematology and Oncology, University of Fukui Hospital, Fukui, Japan.; Fukuhara S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Tanoue Y; Chordia Therapeutics Inc, Kanagawa, Japan.; Yamamoto M; Chordia Therapeutics Inc, Kanagawa, Japan.; Tozaki H; Chordia Therapeutics Inc, Kanagawa, Japan.; Takahara E; Chordia Therapeutics Inc, Kanagawa, Japan.; Shoji S; Chordia Therapeutics Inc, Kanagawa, Japan.; Mizutani A; Chordia Therapeutics Inc, Kanagawa, Japan.; Morishita D; Chordia Therapeutics Inc, Kanagawa, Japan.; Oda R; Chordia Therapeutics Inc, Kanagawa, Japan.; Miyake H; Chordia Therapeutics Inc, Kanagawa, Japan.; Yamamoto N; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Maziarz RT; Oregon Health and Science University Knight Cancer Institute, Portland, OR.; Bishop MR; The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL.; Tam CS; Alfred Hospital and Monash University, Melbourne, VIC, Australia.; Borchmann P; Clinic I for Internal Medicine, University Hospital of Cologne, Cologne, Germany.; Worel N; Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna, Austria.; McGuirk JP; University of Kansas Medical Center, Westwood, KS.; Holte H; Department of Oncology, Oslo University Hospital and KG Jebsen Center for B-Cell Malignancies, Oslo, Norway.; Waller EK; Bone Marrow and Stem Cell Transplant Center, Emory University Winship Cancer Institute, Atlanta, GA.; Jaglowski S; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI.; Andreadis C; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.; Foley SR; Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada.; Westin JR; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX.; Fleury I; Department of Lymphoma and Myeloma, Maisonneuve-Rosemont Hospital, Institut universitaire d'hématologie-oncologie et de thérapie cellulaire, University of Montreal, Montreal, QC, Canada.; Ho PJ; Institute of Haematology, Royal Prince Alfred Hospital and University of Sydney, Camperdown, NSW, Australia.; Mielke S; Department of Medicine II, University of Würzburg Medical Center, Würzburg, Germany.; Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.; Teshima T; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.; Janakiram M; Division of Myeloma, Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA.; Hsu J; Perlmutter Cancer Center, New York University Langone Health, New York, NY.; Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.; Kersten MJ; Department of Hematology, Amsterdam UMC, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands, on behalf of HOVON/LLPC.; Ghosh M; Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI.; Wagner-Johnston N; Department of Oncology, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.; Kato K; Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.; Corradini P; Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milan, Milan, Italy.; Ma W; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Han X; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Nuortti M; Novartis Pharma AG, Basel, Switzerland.; Awasthi R; BioMedical Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Mundt KE; Novartis Pharma AG, Basel, Switzerland.; Majdan M; Novartis Pharmaceuticals Corporation, East Hanover, NJ.; Maier HJ; Novartis Pharma AG, Basel, Switzerland.; Jegerlehner A; Novartis Pharma AG, Basel, Switzerland.; Salles G; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE